CYP2B6 and metabolic dysfunction-associated steatotic liver disease: This suggests that the lack of Cyp2b may increase NAFLD, especially in males, but is protective from progression of the disease to NASH although the data with males is equivocal and in females is may be due to protection from initial damage and NAFLD.